Quantinno Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
11,888
+611
+5% +$85.4K ﹤0.01% 1890
2025
Q4
$1.85M Buy
11,277
+3,768
+50% +$590K ﹤0.01% 1403
2025
Q3
$1M Buy
7,509
+988
+15% +$120K ﹤0.01% 1495
2025
Q2
$811K Buy
6,521
+1,599
+32% +$203K ﹤0.01% 1388
2025
Q1
$626K Buy
4,922
+1,399
+40% +$215K ﹤0.01% 1310
2024
Q4
$507K Buy
3,523
+1,566
+80% +$225K 0.01% 1223
2024
Q3
$291K Buy
1,957
+193
+11% +$27.7K ﹤0.01% 1275
2024
Q2
$222K Buy
1,764
+355
+25% +$55.6K ﹤0.01% 1241
2024
Q1
$259K Buy
+1,409
New +$268K 0.01% 1121
2022
Q4
Sell
-2,118
Closed -$396K 829
2022
Q3
$396K Buy
2,118
+37
+2% +$7.8K 0.05% 427
2022
Q2
$338K Buy
2,081
+763
+58% +$121K 0.05% 424
2022
Q1
$248K Buy
+1,318
New +$250K 0.04% 486

Other funds holding RGEN

Quantinno Capital Management's RGEN Position: Q1 2026 in Review

Quantinno Capital Management increased its Repligen (RGEN) stake by 5.4% in Q1 2026, buying an estimated $85.4K and bringing the position to 11,888 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Quantinno Capital Management first reported a position in RGEN in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.85M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Quantinno Capital Management held 11,888 shares of Repligen worth $1.4M as of Q1 2026.
  • Quantinno Capital Management bought 611 Repligen shares in Q1 2026, an estimated $85.4K.
  • Repligen made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1890 holding.
  • Quantinno Capital Management first reported a position in Repligen in Q1 2022 and has held it in 12 quarters since.
  • Quantinno Capital Management's Repligen position peaked at $1.85M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.